Clinical Guideline InSights

ASGE Endoscopic Management of Benign and Malignant Colonic Strictures 2026 Guideline

4 min · 15 jun 2026
aflevering ASGE Endoscopic Management of Benign and Malignant Colonic Strictures 2026 Guideline artwork

Beschrijving

The 2026 Endoscopic Management of Benign and Malignant Colonic Strictures guideline, highlighting key recommendations across colonic obstruction, selection of self-expandable metal stent, endoscopic balloon dilation, and more.  * Endoscopic Management of Benign and Malignant Colonic Strictures * American Society for Gastrointestinal Endoscopy * June 4, 2026 * Guideline Summary: https://www.guidelinecentral.com/guideline/5224508/ [https://www.guidelinecentral.com/guideline/5224508/] * Full-Text: https://www.giejournal.org/article/S0016-5107(26)00210-5/fulltext [https://www.giejournal.org/article/S0016-5107(26)00210-5/fulltext]

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Clinical Guideline InSights community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

57 afleveringen

aflevering ACC 2026 Statements: Prevention of Thrombotic Events/Antiplatelet Therapy in the Management of ASCVD artwork

ACC 2026 Statements: Prevention of Thrombotic Events/Antiplatelet Therapy in the Management of ASCVD

The 2026 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events Scientific Statement and the 2026 Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease Scientific Statement * Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events/Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease * American College of Cardiology * June 30, 2026 * Guideline Summary: https://www.guidelinecentral.com/guideline/5230408/ [https://www.guidelinecentral.com/guideline/5230408/] / https://www.guidelinecentral.com/guideline/5230407/ [https://www.guidelinecentral.com/guideline/5230407/]  * Full-Text:  https://www.jacc.org/doi/10.1016/j.jacc.2026.05.033 [https://www.jacc.org/doi/10.1016/j.jacc.2026.05.033] / https://www.jacc.org/doi/10.1016/j.jacc.2026.05.037#tbl2 [https://www.jacc.org/doi/10.1016/j.jacc.2026.05.037#tbl2]

16 jul 202617 min